Calcium acetate
Calcium Acetate is a prescription medication available as 667 mg oral capsules, used as a phosphate binder to help manage high phosphate levels in the blood, often in people with kidney disease. It works by binding to phosphate in the diet to reduce its absorption. Manufactured by Square Pharmaceuticals Limited under ANDA217205. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Calcium Acetate is a prescription medication available as 667 mg oral capsules, used as a phosphate binder to help manage high phosphate levels in the blood, often in people with kidney disease. It works by binding to phosphate in the diet to reduce its absorption. Manufactured by Square Pharmaceuticals Limited under ANDA217205. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Calcium acetate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Calcium acetate — ANDA 211038 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211038"
}
]
|
| identifier | ANDA211038 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Calcium acetate |
